Skip to main content

Security report for ibsausa.com

IBSA Pharma Inc. · Healthcare · United States

Medium risk. 3 critical or high findings in Email security, Security headers and 1 other check.

Security score

75/100

Risk levelMedium

0–100, higher is better. How it is calculated

IBSA Pharma Inc. is the U.S. subsidiary of the Swiss multinational pharmaceutical company IBSA Group, with a strong presence in over 90 countries and 20 subsidiaries worldwide. The website presents a professional and comprehensive overview of the company's pillars, therapeutic areas, corporate documents, and sustainability initiatives, targeting healthcare professionals and partners in the pharmaceutical industry. The digital infrastructure employs modern technologies including Bootstrap, jQuery, Google Analytics, Matomo, and Google Tag Manager, ensuring a responsive and user-friendly experience across devices. Security posture is solid with HTTPS enforced and cookie consent mechanisms in place, though explicit security headers and incident response information are not published. The absence of WHOIS registration data raises some concerns about domain legitimacy, but the overall branding and content strongly support the site's authenticity as a corporate entity. Strategic recommendations include enhancing security header implementation, publishing a security policy, and verifying domain registration details to strengthen trust and compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching ibsausa.com

This scan found 19 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
82
Security headers
45
Email security
60
DNS health
75
Network security
100
GDPR outside view
88
Average
75

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

IBSA Pharma Inc. operates as a pharmaceutical manufacturer and distributor, leveraging its parent company IBSA Group's global footprint. The company focuses on therapeutic areas such as endocrinology, pain and inflammation, and reproductive medicine. Its business model centers on research, development, and distribution of pharmaceutical products with a commitment to sustainability and quality. The website's linkage to multiple international subsidiaries and partner organizations reflects a broad partnership ecosystem. Growth indicators include recent news updates and corporate documentation availability. The company targets healthcare professionals and patients, positioning itself as a trusted pharmaceutical provider in the U.S. market.

Security posture

The website demonstrates a mature security posture with enforced HTTPS and cookie consent compliance aligned with GDPR. However, the lack of explicit security headers such as Content-Security-Policy and absence of published security policies or incident response contacts indicate areas for improvement. No vulnerabilities or exposed sensitive data were detected in the HTML content. The use of reputable analytics tools with privacy considerations further supports compliance. Overall, the security maturity is good but could be enhanced by formalizing security documentation and disclosure mechanisms.

Recommendations

  1. Implement and explicitly configure security headers including Content-Security-Policy, X-Frame-Options, X-Content-Type-Options, and Referrer-Policy.
  2. Publish a dedicated security policy page and provide incident response contact information to improve transparency and readiness.
  3. Verify and update WHOIS domain registration information to ensure legitimacy and trustworthiness.
  4. Enhance contact information by providing verified company emails and phone numbers for better user support and compliance.
  5. Consider adding a vulnerability disclosure policy or security.txt file to facilitate responsible reporting.

Contact details published on the site

Addresses
Legal name
IBSA Pharma Inc.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
IBSA Pharma Inc.
Description
IBSA Pharma Inc. is the U.S. subsidiary of IBSA Group, the Swiss multinational pharmaceutical company headquartered in Lugano, Switzerland.
Key services
Pharmaceutical products, Research and development, Sustainability initiatives
Content quality
excellent
Branding
consistent

Technology

Stack
jQuery 3.7.1, Bootstrap, Google Analytics, Google Tag Manager, Matomo Analytics, LazySizes, Swiper.js
Frameworks
Bootstrap
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data in HTML
  • Use of secure analytics tools

Analytics and tracking

Services
Google Analytics, Matomo
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Matomo
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenge
  2. Content is professional, well-structured, and relevant to pharmaceutical industry
  3. Strong branding consistency with parent IBSA Group
  4. Comprehensive privacy and cookie policies with consent mechanisms
  5. No direct company contact emails or phone numbers found in HTML, only contact page link
  6. No explicit security policy or incident response information published
  7. Use of modern web technologies and analytics tools
  8. WHOIS data missing, raising some legitimacy questions
Technical notes

Notes

The website uses a modern technology stack with Bootstrap for responsive design, jQuery for DOM manipulation, and Swiper.js for interactive sliders. Analytics are handled via Google Analytics and Matomo, providing comprehensive tracking capabilities. The site is mobile optimized with good accessibility features and SEO meta tags. Performance is moderate, with lazy loading of images and asynchronous script loading. The CMS appears custom or proprietary, with no common CMS detected. Technical risks are minimal, but the absence of some security headers and incomplete WHOIS data represent areas for technical and operational improvement.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with ibsausa.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review ibsausa.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.